|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S1
|
$63,490
|
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
3P20CA192976-02S1
|
$20,000
|
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
PTEN and the molecular genetics of endometrial cancer
|
5R01CA097097-08
|
$1
|
$1
|
DI CRISTOFANO, ANTONIO
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S1
|
$249,624
|
$4,992
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S2
|
$249,624
|
$4,992
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
3P30CA013330-39S3
|
$74,922
|
$1,498
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Core Support for Cancer Center
|
5P30CA013330-39
|
$3,725,702
|
$74,514
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Role of the Sex Hormones and Insulin/IGF-Axes in Endometrial Cancer Recurrence
|
5R01CA133010-03
|
$482,404
|
$482,404
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Markers of Cognitive Decline During Treatment for Childhood ALL
|
5R21CA187226-02
|
$215,938
|
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
RTOG Biospecimen Repository
|
2U24CA114734-06
|
$1,040,063
|
$104,006
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
3U24CA114734-05S2
|
|
$0
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Supplement to Promote Diversity: Looming Vulnerability and Smoking Cessation Attempts
|
3R15CA198838-01S1
|
$30,988
|
|
HAAGA, DAVID
|
AMERICAN UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
3R01CA198915-02S1
|
$31,147
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Role of Sympathetic Activation and RANKL/IL6 in Breast Cancer Bone Metastasis
|
7R01CA168717-04
|
$323,700
|
|
ELEFTERIOU, FLORENT
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
3P50CA126752-10S1
|
$300,703
|
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
4P50CA126752-10
|
$2,344,258
|
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cognitive Change after Proton RT vs. Photon or Surgery for Pediatric Brain Tumor
|
5R01CA187202-03
|
$102,827
|
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Lung Cancer Prediction Models Incorporating Exome Data from Extreme Phenotypes
|
5K07CA181480-03
|
$127,939
|
|
LIU, YANHONG
|
BAYLOR COLLEGE OF MEDICINE
|
|
TRANSCRIPTION FACTORS IN INTESTINAL DIFFERENTIATION AND CANCER
|
1F99CA212433-01
|
$45,076
|
|
LO, YUAN-HUNG
|
BAYLOR COLLEGE OF MEDICINE
|
|
The Role of Growth Factor Receptor Trafficking in Tumorigenesis
|
3R01CA166749-04S1
|
$13,734
|
|
ZAGE, PETER
|
BAYLOR COLLEGE OF MEDICINE
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
1UH2CA213385-01
|
$25,705
|
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Risk factors for molecular subtypes of NHL a prospective evaluation
|
1R01CA202712-01A1
|
$752,796
|
|
WANG, SOPHIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient
|
5U01CA183012-03
|
$106,075
|
|
ZAIA, JOHN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Quantitative Epigenetic Test for Guiding Smoking Cessation Therapy
|
1R44CA213507-01
|
$642,097
|
|
PHILIBERT, ROBERT
|
BEHAVIORAL DIAGNOSTICS, INC.
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
$11,394
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT
|
3R01CA183605-04S1
|
$355,157
|
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Randomized Trial of a Mammography Decision Aid for Women Aged 75 and Older
|
3R01CA181357-03S1
|
$132,190
|
|
SCHONBERG, MARA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Self-Management and Support for Adolescents and Young Adults with Cancer
|
1R43CA206666-01A1
|
$224,911
|
|
DONOVAN, ELIZABETH
|
BODIMOJO, INC
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Multidisciplinary Training in Image-Guided Therapy
|
5R25CA089017-09
|
$452,146
|
$90,429
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Microbial Exposures across the Lifespan and Cancer Risk in Women
|
5R21CA152839-02
|
$178,238
|
$26,736
|
CLARKE, CHRISTINA
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Breast Cancer Family Registry Cohort
|
4UM1CA164920-05
|
$2,519,194
|
|
JOHN, ESTHER
|
CANCER PREVENTION INSTIT OF CALIFORNIA
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-28
|
$794,063
|
$7,941
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
|
3U54CA163060-05S1
|
$462,954
|
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Repurposing Anti-cancer Drugs to Prevent Growth of Osteosarcoma Metastases
|
1R21CA209304-01
|
$172,369
|
|
GREENFIELD, EDWARD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Image-guided EMT inhibition for treating metastatic breast cancer
|
5R01CA194518-02
|
$473,853
|
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
3P50CA150964-05S1
|
$1,100,000
|
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting B cell activating factor receptor (BAFF-R) as a novel therapeutic strategy for drug resistant Acute Lymphoblastic Leukemia (ALL)
|
1R21CA201775-01A1
|
$206,843
|
|
PARAMESWARAN, RESHMI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Glial tumor image-guided surgery and treatment
|
1R01CA209921-01
|
$544,935
|
|
HOLLER, EGGEHARD
|
CEDARS-SINAI MEDICAL CENTER
|
|
Gut-Related Markers and Hepatocellular Cancer in a Multi-Ethnic Cirrhotic Cohort
|
1R01CA204145-01A1
|
$440,818
|
|
HUSSAIN, SHEHNAZ
|
CEDARS-SINAI MEDICAL CENTER
|
|
Prevention of Depression in Head and Neck Cancer
|
1R21CA197023-01A1
|
$190,313
|
|
IRWIN, SCOTT
|
CEDARS-SINAI MEDICAL CENTER
|
|
ERASE - A new dual thermal ablation/SCN device system for treating pancreatic cancer
|
1R43CA206581-01A1
|
$295,410
|
|
VAN BUSKIRK, ROBERT
|
CELL PRESERVATION SERVICES, INC.
|
|
CDU-UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143931-07
|
$1,802,043
|
$54,061
|
VADGAMA, JAYDUTT
|
CHARLES R. DREW UNIVERSITY OF MED & SCI
|
|
PHASE I SBIR CONTRACT - TOPIC 343 - CHARLES RIVER ANALYTICS, INC. - PH I CONTRACT
|
261201600060C
|
$224,896
|
|
UNKNOWN, UNKNOWN
|
CHARLES RIVER ANALYTICS, INC.
|
|
Structural Variation in Neuroblastoma
|
1R01CA204974-01A1
|
$384,300
|
|
DISKIN, SHARON
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Altered mitochondria-ER signaling as a cause of chemotherapy resistance
|
1R21CA198430-01A1
|
$193,314
|
|
HOGARTY, MICHAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
|
4K07CA166177-04
|
$164,901
|
|
MOSTOUFI-MOAB, SOGOL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
S1P Lyase in colon cancer
|
3R01CA129438-09S2
|
$39,300
|
|
OSKOUIAN, BABAK
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
Total relevant funding to Uterine for this search: $16,505,906
|